Literature DB >> 6489104

Injection treatment of endocrine orbital myopathy.

A B Scott.   

Abstract

Eight patients with endocrine orbital myopathy received botulinum toxin injection of extraocular muscles for strabismus or injections of the levator for lid retraction. Strabismus of 25 prism diopters or less, especially during early stages of eye muscle involvement, responded well to injection with realignment and, probably, with avoidance of fixed muscle shortening. Long-standing strabismus, large angles, and lid retraction responded less well.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6489104     DOI: 10.1007/bf00140912

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  9 in total

1.  Chemodenervation of extraocular muscles with botulinum toxin in thyroid eye disease.

Authors:  David B Granet; Nickisa Hodgson; Kyle J Godfrey; Ricardo Ventura; Don O Kikkawa; Leah Levi; Michael Kinori
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-02-10       Impact factor: 3.117

2.  Botulinum toxin: a new ally of an old adversary.

Authors:  R C Humphry
Journal:  BMJ       Date:  1989-01-21

3.  Botulinum A toxin treatment for eyelid spasm, spasmodic torticollis and apraxia of eyelid opening.

Authors:  G Defazio; V Lepore; P Lamberti; P Livrea; E Ferrari
Journal:  Ital J Neurol Sci       Date:  1990-06

4.  Inferior oblique surgery for restrictive strabismus in patients with thyroid orbitopathy.

Authors:  Steven A Newman
Journal:  Trans Am Ophthalmol Soc       Date:  2009-12

5.  The graded levator hinge procedure for the correction of upper eyelid retraction (an American Ophthalmological Society thesis).

Authors:  Daniel P Schaefer
Journal:  Trans Am Ophthalmol Soc       Date:  2007

6.  [Botulinum toxin injections for the treatment of strabismus. Which indications are still useful today?].

Authors:  T Krzizok
Journal:  Ophthalmologe       Date:  2007-09       Impact factor: 1.059

Review 7.  [Botulinum toxin treatment for crocodile tears, spastic entropion and for dysthyroid upper eyelid retraction].

Authors:  B Wabbels; M Förl
Journal:  Ophthalmologe       Date:  2007-09       Impact factor: 1.174

8.  [Management of moderate and severe dysthyroid orbitopathy: about 22 cases].

Authors:  Nadia Daldoul; Leila Knani; Faten Gatfaoui; Hechmi Mahjoub
Journal:  Pan Afr Med J       Date:  2017-08-07

9.  Update on thyroid eye disease and management.

Authors:  Erick D Bothun; Ryan A Scheurer; Andrew R Harrison; Michael S Lee
Journal:  Clin Ophthalmol       Date:  2009-10-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.